Modulating the Effect of β-Sitosterol Conjugated with Magnetic Nanocarriers to Inhibit EGFR and Met Receptor Cross Talk

Overview

Journal Pharmaceutics

Publisher MDPI

Date 2023 Aug 26

PMID 37631372

Authors

Shanmuga Sundari Ilangovan

Biswanath Mahanty

Venkatesan Perumal

Shampa Sen

Affiliations

Soon will be listed here.

Abstract

The cross-talk between the EGFR (Epidermal Growth Factor Receptor) and MET (Hepatocyte Growth Factor Receptor) poses a significant challenge in the field of molecular signaling. Their intricate interplay leads to dysregulation and contributes to cancer progression and therapeutic resistance. β-Sitosterol (BS), a plant sterol with promising anticancer properties, shows increased research on its potential as a chemopreventive agent. However, significant modifications are required to deliver BS in cancer cells due to its lower efficacy. The present work aims to design a carrier-mediated delivery system specifically targeting cancer cells with EGFR and MET receptor cross-talk. Surface modification of BS was performed with superparamagnetic iron oxide nanoparticles (SPIONs), polyethylene glycol (PEG), and poly(N-isopropylacrylamide) (PNIPAM) to enhance the delivery of BS at the target site. BS was conjugated with SPIONs (BS-S), PNIPAM (BS-SP), PEG, and PNIPAM (BS-SPP) polymers, respectively, and the conjugated complexes were characterized. Results showed an increase in size, stability, and monodispersity in the following order, BS-S, BS-SP, and BS-SPP. The drug encapsulation efficiency was observed to be highest in BS-SPP (82.5%), compared to BS-S (61%) and BS-SP (74.9%). Sustained drug release was achieved in both BS-SP (82.6%) and BS-SPP (83%). The IC 50 value of BS, BS-S, BS-SP, and BS-SPP towards MCF 7 was 242 µg/mL,197 µg/mL, 168 µg/mL, and 149 µg/mL, HEPG2 was 274 µg/mL, 261 µg/mL, 233 µg/mL and 207 µg/mL and NCIH 460 was 191 µg/mL, 185 µg/mL, 175 and 164 µg/mL, indicating highest inhibition towards NCIH 460 cells. Our results conclude that β-sitosterol conjugated with SPION, PEG, and PNIPAM could be a potential targeted therapy in inhibiting EGFR and MET receptor-expressing cancer cells.

Citing Articles

β-Sitosterol-Dietary sources and role in cancer and diabetes management.

Adhimoolam K, Sureshbabu A, Smirnova E, Muthuramalingam P, Do Thi C, Senthil K Food Sci Nutr. 2024; 12(11):8870-8886.

PMID: 39619995 PMC: 11606809. DOI: 10.1002/fsn3.4380.

References

Rietscher R, Czaplewska J, Majdanski T, Gottschaldt M, Schubert U, Schneider M . Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release. Int J Pharm. 2016; 500(1-2):187-95. DOI: 10.1016/j.ijpharm.2016.01.021. View

Prabha G, Raj V . Formation and characterization of β-cyclodextrin (β-CD) - polyethyleneglycol (PEG) - polyethyleneimine (PEI) coated Fe3O4 nanoparticles for loading and releasing 5-Fluorouracil drug. Biomed Pharmacother. 2016; 80:173-182. DOI: 10.1016/j.biopha.2016.03.015. View

Zaichik S, Steinbring C, Jelkmann M, Bernkop-Schnurch A . Zeta potential changing nanoemulsions: Impact of PEG-corona on phosphate cleavage. Int J Pharm. 2020; 581:119299. DOI: 10.1016/j.ijpharm.2020.119299. View

Torchilin V . Tumor delivery of macromolecular drugs based on the EPR effect. Adv Drug Deliv Rev. 2010; 63(3):131-5. DOI: 10.1016/j.addr.2010.03.011. View

Yu Y, Sun D . Superparamagnetic iron oxide nanoparticle 'theranostics' for multimodality tumor imaging, gene delivery, targeted drug and prodrug delivery. Expert Rev Clin Pharmacol. 2011; 3(1):117-30. DOI: 10.1586/ecp.09.39. View

Wei H, Hu Y, Wang J, Gao X, Qian X, Tang M . Superparamagnetic Iron Oxide Nanoparticles: Cytotoxicity, Metabolism, and Cellular Behavior in Biomedicine Applications. Int J Nanomedicine. 2021; 16:6097-6113. PMC: 8418330. DOI: 10.2147/IJN.S321984. View

Lai L, Fu Q, Liu Y, Jiang K, Guo Q, Chen Q . Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacol Sin. 2012; 33(4):523-30. PMC: 4003369. DOI: 10.1038/aps.2011.209. View

Cao H, Cheng C, Su T, Fu X, Guo H, Li T . Quercetin inhibits HGF/c-Met signaling and HGF-stimulated melanoma cell migration and invasion. Mol Cancer. 2015; 14:103. PMC: 4435529. DOI: 10.1186/s12943-015-0367-4. View

Takahashi A, Ozaki Y, Kuzuya A, Ohya Y . Impact of core-forming segment structure on drug loading in biodegradable polymeric micelles using PEG-b-poly(lactide-co-depsipeptide) block copolymers. Biomed Res Int. 2014; 2014:579212. PMC: 3950643. DOI: 10.1155/2014/579212. View

10.

Shamim N, Hong L, Hidajat K, Uddin M . Thermosensitive polymer (N-isopropylacrylamide) coated nanomagnetic particles: preparation and characterization. Colloids Surf B Biointerfaces. 2006; 55(1):51-8. DOI: 10.1016/j.colsurfb.2006.11.007. View

11.

Podila R, Brown J . Toxicity of engineered nanomaterials: a physicochemical perspective. J Biochem Mol Toxicol. 2012; 27(1):50-5. PMC: 3778677. DOI: 10.1002/jbt.21442. View

12.

Maeda H, Sawa T, Konno T . Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS. J Control Release. 2001; 74(1-3):47-61. DOI: 10.1016/s0168-3659(01)00309-1. View

13.

Adan A, Alizada G, Kiraz Y, Baran Y, Nalbant A . Flow cytometry: basic principles and applications. Crit Rev Biotechnol. 2016; 37(2):163-176. DOI: 10.3109/07388551.2015.1128876. View

14.

Kulkarni N, Vaidya B, Gupta V . Nano-synergistic combination of Erlotinib and Quinacrine for non-small cell lung cancer (NSCLC) therapeutics - Evaluation in biologically relevant in-vitro models. Mater Sci Eng C Mater Biol Appl. 2021; 121:111891. DOI: 10.1016/j.msec.2021.111891. View

15.

Xu H, Cheng L, Wang C, Ma X, Li Y, Liu Z . Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials. 2011; 32(35):9364-73. DOI: 10.1016/j.biomaterials.2011.08.053. View

16.

Gupta A, Gupta M . Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials. 2005; 26(18):3995-4021. DOI: 10.1016/j.biomaterials.2004.10.012. View

17.

Liechty W, Kryscio D, Slaughter B, Peppas N . Polymers for drug delivery systems. Annu Rev Chem Biomol Eng. 2012; 1:149-73. PMC: 3438887. DOI: 10.1146/annurev-chembioeng-073009-100847. View

18.

Saxena N, Agraval H, Barick K, Ray D, Aswal V, Singh A . Thermal and microwave synthesized SPIONs: Energy effects on the efficiency of nano drug carriers. Mater Sci Eng C Mater Biol Appl. 2020; 111:110792. DOI: 10.1016/j.msec.2020.110792. View

19.

Kawk H, Nam G, Kim M, Kim S, Kim Y . Ethanol Extract Induces Anoikis by Regulating the EGFR/Akt Pathway in HCT116 Colorectal Cancer Cells. Front Oncol. 2021; 11:621346. PMC: 8173041. DOI: 10.3389/fonc.2021.621346. View

20.

Ding Y, Shen S, Sun H, Sun K, Liu F, Qi Y . Design and construction of polymerized-chitosan coated Fe3O4 magnetic nanoparticles and its application for hydrophobic drug delivery. Mater Sci Eng C Mater Biol Appl. 2015; 48:487-98. DOI: 10.1016/j.msec.2014.12.036. View